Drugs that contain Venlafaxine Hydrochloride
1. Effexor Xr patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310101 | UPJOHN | Treatments using venlafaxine |
Jun, 2013
(10 years ago) | |
| US6444708 | UPJOHN | Treatment using venlafaxine |
Jun, 2013
(10 years ago) | |
| US5916923 | UPJOHN | Venlafaxine for the treatment of generalized anxiety disorder |
Jun, 2013
(10 years ago) | |
|
US5916923 (Pediatric) | UPJOHN | Venlafaxine for the treatment of generalized anxiety disorder |
Dec, 2013
(10 years ago) | |
|
US6444708 (Pediatric) | UPJOHN | Treatment using venlafaxine |
Dec, 2013
(10 years ago) | |
| US6403120 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
| US6419958 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
| US6274171 | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
|
US6274171 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
|
US6403120 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
|
US6419958 (Pediatric) | UPJOHN | Extended release formulation of venlafaxine hydrochloride |
Sep, 2017
(6 years ago) | |
Market Authorisation Date: 20 October, 1997
Treatment: Treatment of panic disorder; Treatment of generalized anxiety disorder; Treatment of depression and generalized anxiety disorder; Treatment of social anxiety disorder
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of EFFEXOR XR before it's drug patent expiration?
More Information on Dosage
EFFEXOR XR family patents
2. Venlafaxine Hydrochloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6419958 | OSMOTICA PHARM US | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
| US6403120 | OSMOTICA PHARM US | Extended release formulation of venlafaxine hydrochloride |
Mar, 2017
(7 years ago) | |
Market Authorisation Date: 20 May, 2008
Treatment: Treatment of social anxiety disorder
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of VENLAFAXINE HYDROCHLORIDE before it's drug patent expiration?
More Information on Dosage
VENLAFAXINE HYDROCHLORIDE family patents